Trump wanted to advance the ‘most favored nation’ policy in his first term but faced resistance from industry and the courts.

In a bold move, President Trump has signed an executive order to slash drug prices in the U.S., aligning them with the lowest prices globally. This 'nation most favored' pricing strategy could revolutionize the pharmaceutical landscape,

POLITICO reports Trump wanted the ‘most favored nation’ policy in his first term but faced resistance from the pharmaceutical industry and the courts.